Chemerin and prediction of Diabetes mellitus type 2

Clinical Endocrinology

Volumn 82, Issue 6, 2015, Pages 838-843

  Bobbert, Thomas ^a   Schwarz, Franziska ^a   Fischer Rosinsky, Antje ^a   Maurer, Lukas ^a   Möhlig, Matthias ^a   Pfeiffer, A F H ^a,b   Mai, Knut ^a   Spranger, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; GLYCOSYLATED HEMOGLOBIN; SIGNAL PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SECONDARY ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; DIABETES MELLITUS, TYPE 2; GERMANY; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS;

BODY MASS INDEX; CHEMOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84929698745     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12707     Document Type: Article

References (44)

1. Scarpellini, E., &, Tack, J., (2012) Obesity and metabolic syndrome: an inflammatory condition. Digestive Diseases, 30, 148-153.
2. Caspar-Bauguil, S., Cousin, B., Bour, S., et al,. (2009) Adipose tissue lymphocytes: types and roles. Journal of Physiology and Biochemistry, 65, 423-436.
3. Weisberg, S.P., McCann, D., Desai, M., et al,. (2003) Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation, 112, 1796-1808.
4. Anderson, E.K., Gutierrez, D.A., &, Hasty, A.H., (2010) Adipose tissue recruitment of leukocytes. Current Opinion in Lipidology, 21, 172-177.
5. Trayhurn, P., &, Wood, I.S., (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochemical Society Transactions, 33 (Pt 5), 1078-1081.
6. Kern, P.A., Ranganathan, S., Li, C., et al,. (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology. Endocrinology and Metabolism, 280, E745-E751.
7. Cottam, D.R., Mattar, S.G., Barinas-Mitchell, E., et al,. (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obesity Surgery, 14, 589-600.
8. Nagpal, S., Patel, S., Jacobe, H., et al,. (1997) Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. The Journal of Investigative Dermatology, 109, 91-95.
9. Bozaoglu, K., Bolton, K., McMillan, J., et al,. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148, 4687-4694.
10. Wittamer, V., Franssen, J.D., Vulcano, M., et al,. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine, 198, 977-985.
11. Goralski, K.B., McCarthy, T.C., Hanniman, E.A., et al,. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry, 282, 28175-28188.
12. Zabel, B.A., Nakae, S., Zuniga, L., et al,. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. Journal of Experimental Medicine, 205, 2207-2220.
13. Du, X.Y., Zabel, B.A., Myles, T., et al,. (2009) Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. Journal of Biological Chemistry, 284, 751-758.
14. Yang, M., Yang, G., Dong, J., et al,. (2010) Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. Journal of Investigative Medicine, 58, 883-886.
15. Takahashi, M., Inomata, S., Okimura, Y., et al,. (2013) Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism. Endocrine Journal, 60, 37-44.
16. Chakaroun, R., Raschpichler, M., Kloting, N., et al,. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism, 61, 706-714.
17. Sell, H., Divoux, A., Poitou, C., et al,. (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism, 95, 2892-2896.
18. Docke, S., Lock, J.F., Birkenfeld, A.L., et al,. (2013) Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology, 169, 547-557.
19. Stejskal, D., Karpisek, M., Hanulova, Z., et al,. (2008) Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 152, 217-221.
20. Ouwens, D.M., Bekaert, M., Lapauw, B., et al,. (2012) Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome. Archives of Physiology and Biochemistry, 118, 135-138.
21. Weigert, J., Neumeier, M., Wanninger, J., et al,. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology (Oxford), 72, 342-348.
22. Gu, P., Jiang, W., Lu, B., et al,. (2014) Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients. Clinical and Experimental Hypertension, 36, 326-332.
23. Guzel, E.C., Celik, C., Abali, R., et al,. (2014) Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecological Endocrinology, 30, 419-422.
24. Kim, S.H., Lee, S.H., Ahn, K.Y., et al,. (2014) Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clinical Endocrinology (Oxford), 80, 825-833.
25. Neuparth, M.J., Proenca, J.B., Santos-Silva, A., et al,. (2014) The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. Journal of Investigative Medicine, 62, 350-353.
26. Spiroglou, S.G., Kostopoulos, C.G., Varakis, J.N., et al,. (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. Journal of Atherosclerosis and Thrombosis, 17, 115-130.
27. Yoo, H.J., Choi, H.Y., Yang, S.J., et al,. (2012) Circulating chemerin level is independently correlated with arterial stiffness. Journal of Atherosclerosis and Thrombosis, 19, 59-66.
28. Lehrke, M., Becker, A., Greif, M., et al,. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology, 161, 339-344.
29. Yan, Q., Zhang, Y., Hong, J., et al,. (2012) The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine, 41, 281-288.
30. Dong, B., Ji, W., &, Zhang, Y., (2011) Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Internal Medicine, 50, 1093-1097.
31. Gao, X., Mi, S., Zhang, F., et al,. (2011) Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovascular Diabetology, 10, 87.
32. Aronis, K.N., Sahin-Efe, A., Chamberland, J.P., et al,. (2014) Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans affairs normative aging study. Metabolism, 63, 760-766.
33. Ernst, M.C., &, Sinal, C.J., (2010) Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism, 21, 660-667.
34. Bobbert, T., Schwarz, F., Fischer-Rosinsky, A., et al,. (2013) Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care, 36, 145-149.
35. Fischer, A., Fisher, E., Mohlig, M., et al,. (2008) KCNJ11 E23K affects diabetes risk and is associated with the disposition index: results of two independent German cohorts. Diabetes Care, 31, 87-89.
36. Alberti, K.G., &, Zimmet, P.Z., (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
37. Stumvoll, M., Mitrakou, A., Pimenta, W., et al,. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 23, 295-301.
38. Fischer-Rosinsky, A., Fisher, E., Kovacs, P., et al,. (2008) Lack of association between the tagging SNP A + 930→G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS ONE, 3, e3852.
39. Takahashi, M., Takahashi, Y., Takahashi, K., et al,. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters, 582, 573-578.
40. Kralisch, S., Weise, S., Sommer, G., et al,. (2009) Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regulatory Peptides, 154, 102-106.
41. Ernst, M.C., Issa, M., Goralski, K.B., et al,. (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology, 151, 1998-2007.
42. Ernst, M.C., Haidl, I.D., Zuniga, L.A., et al,. (2012) Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology, 153, 672-682.
43. Sell, H., Laurencikiene, J., Taube, A., et al,. (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes, 58, 2731-2740.
44. Becker, M., Rabe, K., Lebherz, C., et al,. (2010) Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes, 59, 2898-2903.